Неинвазивни ДНК тестове от майчина кръв за оценка на хромозомни заболявания:

1. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.

Galeva S, Konstantinidou L, Gil MM, Akolekar R, Nicolaides KH.

2. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.

Galeva S, Gil MM, Konstantinidou L, Akolekar R, Nicolaides KH.

3. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.

Gil MM, Galeva S, Jani J, Konstantinidou L, Akolekar R, Plana MN, Nicolaides KH. 

4. Non-Invasive Prenatal Testing beyond Trisomies.

Suciu ID, Toader OD, Galeva S, Pop L.

5. First-trimester screening-biomarkers and cell-free DNA.

Suciu I, Galeva S, Abdel Azim S, Pop L, Toader O.

Скрининг за прееклампсия в първия триместър:

Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.

Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, Ajdacka U, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright A, Wright D, Nicolaides KH.

Плацентарна функция:

Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35-37 weeks of gestation.

Garcia-Gonzalez C, Abdel-Azim S, Galeva S, Georgiopoulos G, Nicolaides KH, Charakida M.